Controversies surrounding the use of beta-blockers in older patients with cardiovascular disease

dc.contributor.author	Jansen, R. W.
dc.contributor.author	Gurwitz, Jerry H.
dc.date	2022-08-11T08:09:21.000
dc.date.accessioned	2022-08-23T16:27:29Z
dc.date.available	2022-08-23T16:27:29Z
dc.date.issued	1994-03-01
dc.date.submitted	2009-09-29
dc.identifier.citation	Drugs Aging. 1994 Mar;4(3):175-83.
dc.identifier.issn	1170-229X
dc.identifier.pmid	7911042
dc.identifier.uri	http://hdl.handle.net/20.500.14038/36795
dc.language.iso	en_US
dc.relation	<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=7911042&dopt=Abstract">Link to article in PubMed</a>
dc.relation.url	http://adisonline.com/aging/Citation/1994/04030/Controversies_Surrounding_the_Use_of.1.aspx
dc.subject	Adrenergic beta-Antagonists; Age Factors; Aged; Aged, 80 and over; Cardiovascular Diseases; Drug Utilization; Female; Heart Failure; Humans; Male; Myocardial Infarction
dc.subject	Health Services Research
dc.subject	Medicine and Health Sciences
dc.title	Controversies surrounding the use of beta-blockers in older patients with cardiovascular disease
dc.type	Journal Article
dc.source.journaltitle	Drugs and aging
dc.source.volume	4
dc.source.issue	3
dc.identifier.legacycoverpage	https://escholarship.umassmed.edu/meyers_pp/157
dc.identifier.contextkey	1019648
dc.identifier.submissionpath	meyers_pp/157
dc.contributor.department	Department of Medicine, Division of Geriatric Medicine
dc.contributor.department	Meyers Primary Care Institute
dc.source.pages	175-83